Advertisement
Organisation › Details
Oxford Science Park, The (TOSP)
The Oxford Science Park is majority owned by Magdalen College, Oxford, upholding its research heritage and its strategy to support discovery, innovation and entrepreneurship. Providing an influential science and technology environment, the Park has ambitious plans to create an additional 500,000+ sq. ft. of office and laboratory space over the next 3 years alongside its strategic partner GIC. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos. TOSP is home to 2,700 people and more than 130 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, MiroBio, OrganOx, OxSonics Therapeutics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Science Enterprises, Evox Therapeutics, Exscientia and Intuitive Surgical. The Oxford Science Park is located approximately four miles south-east of Oxford city centre, just off the City’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. *
Start | 1991-01-01 start | |
Group | University of Oxford | |
Industry | business park management / science park management | |
Industry 2 | LIFE SCIENCES | |
Person | Maw, Rory (Univ Oxford 202207 CEO of The Oxford Science Park) | |
Person 2 | Macpherson, Ian (Oxford Science Park 201105 Business Development Manager) | |
Region | Oxford, Oxfordshire | |
Country | United Kingdom (GB) | |
City | OX4 4GA Oxford | |
Tel | +44-1865-784000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Oxford Science Park, The. (7/18/22). "Press Release: The Oxford Science Park Agrees to Sale of Development Site to the Lawrence J. Ellison Institute for Transformative Medicine". Oxford. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for University of Oxford
- [1] Oxford Science Park, The. (7/18/22). "Press Release: The Oxford Science Park Agrees to Sale of Development Site to the Lawrence J. Ellison Institute for Transformative Medicine". Oxford....
- [2] Oxford VR Ltd.. (4/7/22). "Press Release: OxfordVR Technology a World First Success in Automating Psychological Therapy Using Virtual Reality (VR)"....
- [3] Exscientia Ltd.. (8/4/21). "Press Release: Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline"....
- [4] Bicycle Therapeutics plc. (10/22/19). "Press Release: Bicycle Therapeutics Expands Neuroscience Collaborations to include Oxford University’s Oxford Drug Discovery Institute". Cambridge & Boston, MA....
- [5] Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top